News
Tatva Chintan Pharma Chem consolidated net profit rises 140.30% in the June 2026 quarter
17-Jul-2026 | 17:27
Sales rise 42.96% to Rs 167.06 crore
Net profit of Tatva Chintan Pharma Chem rose 140.30% to Rs 15.98 crore in the quarter ended June 2026 as against Rs 6.65 crore during the previous quarter ended June 2025. Sales rose 42.96% to Rs 167.06 crore in the quarter ended June 2026 as against Rs 116.86 crore during the previous quarter ended June 2025.
| Particulars | Quarter Ended | ||
| Jun. 2026 | Jun. 2025 | % Var. | |
| Sales | 167.06 | 116.86 | 43 |
| OPM % | 19.33 | 14.83 | - |
| PBDT | 33.00 | 18.07 | 83 |
| PBT | 22.43 | 9.10 | 146 |
| NP | 15.98 | 6.65 | 140 |
Powered by Capital Market - Live News